hydroxyurea 500 MG Oral Capsule [Hydrea]
hydroxyurea
RxCUI: 105602
What the CMS Formulary Data Shows for hydroxyurea 500 MG Oral Capsule [Hydrea]
Per the CMS 2026 Part D formulary file, hydroxyurea 500 MG Oral Capsule [Hydrea] (RxNorm concept RXCUI 105602, generic name hydroxyurea) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to hydroxyurea 500 MG Oral Capsule [Hydrea] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 102,368 Part D beneficiaries filled hydroxyurea 500 MG Oral Capsule [Hydrea] in 2023, with total plan-and-beneficiary spending of $17,214,624 and an average per-beneficiary annual cost of $168.16. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry hydroxyurea 500 MG Oral Capsule [Hydrea] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 2
- Coverage rate
- 0%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 102,368
- Total spending
- $17,214,624
- Avg per beneficiary
- $168.16
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering hydroxyurea 500 MG Oral Capsule [Hydrea]
2 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is hydroxyurea 500 MG Oral Capsule [Hydrea] covered by Medicare Part D?
Yes, hydroxyurea 500 MG Oral Capsule [Hydrea] is covered by 2 Medicare Part D plans (0% of all Part D formularies).
What tier is hydroxyurea 500 MG Oral Capsule [Hydrea] on Medicare Part D plans?
hydroxyurea 500 MG Oral Capsule [Hydrea] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does hydroxyurea 500 MG Oral Capsule [Hydrea] require prior authorization?
0% of Part D formularies require prior authorization for hydroxyurea 500 MG Oral Capsule [Hydrea]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on hydroxyurea 500 MG Oral Capsule [Hydrea]?
In 2023, total Medicare Part D spending on hydroxyurea 500 MG Oral Capsule [Hydrea] was $17,214,624, covering 102,368 beneficiaries. The average spend per beneficiary was $168.16.
Read our methodology - how this data is sourced, computed, and verified.